| Product Name | NebuSelect™ Recombinant Human IgG1 Fc |
|---|---|
| Catalog Number | NBL-242517 |
| Alias/Synonyms | IgG1 Fc; IgG1; Igh-4; RGD1359539; VH7183 |
| Appearance | see COA |
| Molecule Weight | |
| CAS | N/A |
| Solubility | Water Soluble |
| Storage | Short term 4℃; Long term -20℃. |
| Shelf Life | 2 years |
| Additional info 1 | P01857-1 |
| Additional info 2 |
| Catalog Numbe | Size | Price | Inventory Level | |
| NBL-242517-100ug | 100ug | Inquire | Inquire | |
| NBL-242517-1mg | 1mg | Inquire | Inquire | |
| NBL-242517-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Human IgG1 Fc
Catalog#:
NBL-242517
Description:
NebuSelect™ Recombinant Human IgG1 Fc(Cat#NBL-242517) is expressed in HEK293 without tag.It contains Asp104-Lys330.
Species:
Human
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 25.5 kDa. Due to glycosylation, the protein migrates to 31-33 kDa based on Bis-Tris PAGE result.
Target Name:
IgG1 Fc; IgG1; Igh-4; RGD1359539; VH7183
Target Information:
IgG1 is most abundant in serum among the four IgG subclasses (IgG1, 2, 3 and 4) and binds to Fc receptors (FcγR) on phagocytic cells with high affinity. Fc fragment is demonstrated to mediate phagocytosis, trigger inflammation, and target Ig to particular tissues.IgG1 Fc was reported has a novel role as a potential anti-inflammatory drug for treatment of human autoimmune diseases.
Amino Acid Sequence:
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.